Trial intelligence / Profile preview

Istaroxime in acute decompensated heart failure (Italy + China, Phase II)

CTR20160151Phase 2Completed

Sponsor
CVie Therapeutics
Start
May 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of istaroxime in heart failure (HF), sponsored by CVie Therapeutics. Started May 2016; status: completed.

02

Drugs

istaroxime
03

Conditions

heart failure (HF)

Beyond the preview

Go deeper on CTR20160151.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20160151.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call